Madrigal Pharmaceuticals Set to Reveal Q3 2024 Financial Results

Madrigal Pharmaceuticals

CONSHOHOCKEN, PAMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced that it will release its third-quarter 2024 financial results on Thursday, Oct. 31, 2024, prior to the opening of U.S. financial markets.

Following this release, Madrigal’s management will conduct a live webcast at 8 a.m. Eastern Time, aimed at reviewing the company’s financial and operational performance.

Interested participants can access the live webcast through the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a smooth connection, it is advisable to register at least 15 minutes before the scheduled start time.

For those unable to attend the live session, a recording of the webcast will be available approximately two hours later.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Larimar Therapeutics Shares Promising Data on Nomlabofusp at Ataxia Research Congress